Jason Lettmann, Director at Ra Pharmaceuticals, Inc. (RARX), bought 1,849,072 shares at $13.00 ($5.1M) on 2016-10-31, disclosed to the SEC on 2016-10-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,392,130 | $0 | 0.0% |
| 2 | $0.07 | 63,019 | $4K | 0.1% |
| 3 | $13.00 | 15,633 | $203K | 4.0% |
| 4 | $13.00 | 114,752 | $1.5M | 29.1% |
| 5 | $13.00 | 263,538 | $3.4M | 66.8% |
| Total | $2.77 avg | 1,849,072 |
| $5.1M |
| 100% |
| Filing → |
| ALXO | BUY | 2025-09-18 | $176K | — | Filing → |
| ALXO | SELL | 2025-08-19 | $2K | — | Filing → |
| ALXO | SELL | 2025-02-21 | $2K | — | Filing → |